A randomized clinical trial of group medical appointments for patients with chronic neuromuscular disease. A comparison with usual care in terms of quality of life and cost-effectiveness

A randomized clinical trial of group medical appointments for patients with chronic neuromuscular disease. A comparison with usual care in terms of quality of life and cost-effectiveness - .

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32749

Enrollment

270

Registered

2009-01-15

Start date

2009-02-06

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle diseases

Interventions

The intervention group takes part in one group medical appointment. This group medical appointment replaces te annual visit to the neurologist of this one patient. The controlgroup receives care as

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Patients are diagnosed with one of the 7 above neuromuscular diseases • Age > 18 years • Patients are control patients in care at the department of neurology RUNMC

Exclusion criteria

Exclusion criteria: • Patients with severe hearing problems • Patients who cannot speak, read or understand the Dutch language well • Patients who have had a control visit with a neurologist at the neurology department of the RUNMC less than 6 months ago

Design outcomes

Primary

Measure	Time frame
Primary outcome measure is Quality of Life (Qualy's),	—

Secondary

Measure	Time frame
secundary outcome measures are Self efficacy, functional activities, patient and partner satisfaction with care and use of care resources.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)